SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Oct 08, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008504.pdf 0001214659-20-008504.rtf 0001214659-20-008504.xls View HTML
Oct 08, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008506.pdf 0001214659-20-008506.rtf 0001214659-20-008506.xls View HTML
Oct 08, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008508.pdf 0001214659-20-008508.rtf 0001214659-20-008508.xls View HTML
Oct 02, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008375.pdf 0001214659-20-008375.rtf 0001214659-20-008375.xls View HTML
Oct 02, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008378.pdf 0001214659-20-008378.rtf 0001214659-20-008378.xls View HTML
Sep 22, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-008039.pdf 0001214659-20-008039.rtf 0001214659-20-008039.xls View HTML
Sep 03, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-007671.pdf 0001214659-20-007671.rtf 0001214659-20-007671.xls View HTML
Aug 14, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-007184.pdf 0001214659-20-007184.rtf 0001214659-20-007184.xls View HTML
Aug 10, 2020	Statement of changes in beneficial ownership of securities	4	0001387131-20-007268.pdf 0001387131-20-007268.rtf 0001387131-20-007268.xls View HTML
Aug 10, 2020	An amendment to a SC 13D filing	SC 13D/A	0001387131-20-007266.pdf 0001387131-20-007266.rtf View HTML

Data provided by Kaleidoscope.